U.S., Jan. 13 -- ClinicalTrials.gov registry received information related to the study (NCT07333378) titled 'Retention of Vernix Caseosa in Newborns for Primary Prevention of Atopic Dermatitis' on Dec. 05, 2025.
Brief Summary: Atopic dermatitis (AD), also known as eczema, is a common chronic inflammatory skin disease that usually begins in infancy and causes significant itching, discomfort, and sleep disturbance. It affects up to one in five children worldwide and represents a growing public-health problem. Research has shown that genetic and environmental factors contribute to its development, especially those related to skin-barrier integrity and the skin microbiome during early life. Preventing AD before it starts-known as primary preve...